LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 434 | 0.0% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 434 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 434 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 434 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 434 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 434 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 434 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 434 | -25.6% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 583 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 583 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 583 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 583 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -50.0% | 583 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | +33.3% | 583 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | -25.0% | 583 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -33.3% | 583 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | -14.3% | 583 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | +40.0% | 583 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | – | 583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |